TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 72 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $543,739 | +526.5% | 172,069 | +31.0% | 0.00% | – |
| Q2 2023 | $86,794 | +23.9% | 131,308 | +49.5% | 0.00% | – |
| Q1 2023 | $70,039 | +31.3% | 87,813 | +272.0% | 0.00% | – |
| Q4 2022 | $53,352 | +11.2% | 23,607 | -5.4% | 0.00% | – |
| Q3 2022 | $48,000 | -81.9% | 24,962 | -65.2% | 0.00% | – |
| Q2 2022 | $265,000 | -76.9% | 71,651 | -59.2% | 0.00% | – |
| Q1 2022 | $1,148,000 | -30.8% | 175,755 | +23.5% | 0.00% | – |
| Q4 2021 | $1,658,000 | -28.8% | 142,345 | +13.8% | 0.00% | – |
| Q3 2021 | $2,328,000 | +203.9% | 125,094 | +246.4% | 0.00% | – |
| Q2 2021 | $766,000 | +64.4% | 36,110 | +57.3% | 0.00% | – |
| Q1 2021 | $466,000 | -44.0% | 22,961 | -26.7% | 0.00% | – |
| Q4 2020 | $832,000 | – | 31,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
| Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
| Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
| Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
| Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
| Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
| TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
| Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |